Description
A DNA-crosslinking agent; halts the cell cycle at the G2/M phase in vitro; active against murine tumors transplanted into mice and in mouse xenograft models; reduces tumor growth in a squamous cell carcinoma mouse xenograft model at doses of 7.5-12.5 mg/kg; inhibits RecA recombinase of M. tuberculosis (IC50 = 2 µM)
Formal name: (SP-4-2)-diamminedichloro-platinum
Synonyms: cis-Diamminedichloroplatinum|CDDP|Cisplatinum|NSC 119875
Molecular weight: 300.1
CAS: 15663-27-1
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Cancer|Cell Cycle|G2/M||Research Area|Cancer|Cell Death||Research Area|Cancer|DNA Damage and Repair||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Bacterial Diseases|Tuberculosis